DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Umbricht D, Martin-Facklam M, Youssef E et al.
Glycine reuptake inhibitor RG1678: results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia.
European Neuropsychopharmacology 2011;
21: S517-S518
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.